Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2007
10/23/2007CA2380052C Nicotine receptor agonists in stem cell and progenitor cell recruitment
10/23/2007CA2350905C Imidazo[4,5-b]pyridiniummethyl-containing cephem compounds having broad antibacterial spectrum
10/23/2007CA2340156C .beta.-l-2'-deoxy-nucleosides for the treatment of hepatitis b
10/23/2007CA2334910C New use of a pyridazinone derivative
10/23/2007CA2295088C Gastrokinetic bicyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivates
10/23/2007CA2280041C Antigestagenic steroids with a fluorinated 17.alpha.-alkyl chain
10/23/2007CA2277992C Process for preparation of 4-deoxyerythromycins a and b
10/23/2007CA2263757C Method to obtain oestrogens from mare's urine
10/23/2007CA2254395C Use of panaverium bromide for preventing cell proliferation and diseases caused thereby in the liver and digestive tract
10/23/2007CA2248266C Immunosuppressive compounds and methods
10/23/2007CA2244209C Improved concentrated injection and infusion solutions for intravenous administration
10/23/2007CA2221900C Use of trospium chloride and 2-component system for the same
10/23/2007CA2217780C Polyether nucleic acids
10/23/2007CA2181910C Process for making avermectin/zein compositions
10/23/2007CA2177961C Use of dimeticone for treating aphthae and stomatitis
10/20/2007CA2542641A1 Dopamine d2 receptor gene variants
10/20/2007CA2541903A1 A method of diagnosis and treatment
10/18/2007WO2007118245A2 Methods and compositions related to adenoassociated virus-phage particles
10/18/2007WO2007118234A2 Modified -galactosyl ceramides for staining and stimulating natural killer t cells
10/18/2007WO2007118227A2 Naphthalenedione compounds
10/18/2007WO2007118226A2 Anthracenedione compounds
10/18/2007WO2007118205A2 Compounds, compositions and methods for treating hormone-dependent maladies
10/18/2007WO2007118198A2 2-METHYLENE-1α,25-DIHYDROXY-19,21-DINORVITAMIN D3 ANALOGS AND USES THEREOF
10/18/2007WO2007118157A1 Enhancing stem cell mobilization
10/18/2007WO2007118151A2 Spirocyclic heterocyclic derivatives and methods of their use
10/18/2007WO2007118149A2 Thiazole and thiophene analogues, and their use in treating autoimmune diseases and cancers
10/18/2007WO2007118136A2 Method for creating a stratigraphic model using pseudocores created from borehole images
10/18/2007WO2007118135A2 Methods for prevention and treatment of conditions arising from local estrogen deficiency
10/18/2007WO2007118131A2 Methods and devices for reducing tissue damage after ischemic injury
10/18/2007WO2007118130A2 Antibacterial agents
10/18/2007WO2007118041A1 Compounds which modulate the cb2 receptor
10/18/2007WO2007118033A1 Treatment of psychiatric patients with sleep disturbances an/or excessive daytime sleepiness with paliperidone
10/18/2007WO2007118023A1 Renin inhibitors for the treatment of hypertension
10/18/2007WO2007118009A1 Prenyltransferase inhibitors for ocular hypertension control and the treatment of glaucoma
10/18/2007WO2007117995A2 Kinase inhibitors
10/18/2007WO2007117982A2 Organic compounds
10/18/2007WO2007117971A2 Ocular allergy treatments
10/18/2007WO2007117923A2 Compositions including relatively water insoluble/unwettable drugs and methods for using same
10/18/2007WO2007117849A2 Use of inhibitors of jun n-terminal kinases to treat glaucoma
10/18/2007WO2007117791A2 Combination treatment of metabolic disorders
10/18/2007WO2007117771A2 Time-release compositions for delivery of [cr3o(carboxylate)6(h2o)3]+
10/18/2007WO2007117715A2 Modulators of atp-binding cassette transporters
10/18/2007WO2007117706A2 Solid oral dosage form containing an enhancer
10/18/2007WO2007117704A2 Pure isomers of tritoqualine
10/18/2007WO2007117699A2 Inhibition of shp2/ptpn11 protein tyrosine phosphatase by nsc-87877, nsc-117199 and their analogs
10/18/2007WO2007117692A2 Thiazoles, imidazoles, and pyrazoles useful as inhibitors of protein kinases
10/18/2007WO2007117687A2 Implants for the treatment of dopamine associated states
10/18/2007WO2007117684A2 Carisoprodol articles and methods
10/18/2007WO2007117653A2 Cdk9-pi3k-akt inhibitors for cancer treatment
10/18/2007WO2007117639A2 Synthesis of tetracyclines and analogues thereof
10/18/2007WO2007117621A1 Use of combination preparations containing thrombin receptor antagonists for treating cardiovascular disorders
10/18/2007WO2007117581A2 Stabilized transdermal bupropion preparations
10/18/2007WO2007117565A2 Standardization of processes for culturing primary cells
10/18/2007WO2007117563A2 1.alpha.-hydroxy-2-(3'-hydroxypropylidene)-19-nor-vitamin d compounds and methods of making and use thereof
10/18/2007WO2007117560A2 Piperidine and morpholine renin inhibitors
10/18/2007WO2007117559A2 Renin inhibitors
10/18/2007WO2007117558A2 Antioxidants and methods of their use
10/18/2007WO2007117557A2 Diaminopropanol renin inhibitors
10/18/2007WO2007117556A2 Pharmaceutical compositions and uses thereof
10/18/2007WO2007117509A2 High delivery rates for lipid based drug formulations, and methods of treatment thereof
10/18/2007WO2007117482A2 Renin inhibitors
10/18/2007WO2007117467A2 Use of tm-601 for the diagnosis and treatment of tumors
10/18/2007WO2007117466A2 Celastrol, gedunin, and derivatives thereof as hsp90 inhibitors
10/18/2007WO2007117465A2 Indazole compounds
10/18/2007WO2007117438A2 Methods for the production of functional protein from dna having a nonsense mutation and the treatment of disorders associated therewith
10/18/2007WO2007117431A2 Use of rasagiline for the treatment of restless legs syndrome
10/18/2007WO2007117419A2 Methods and compositions relating to post-prolyl cleaving enzyme inhibitors
10/18/2007WO2007117413A1 Sulfonyl-3-heterocyclylindazole derivatives as 5-hydroxytryptamine-6 ligands
10/18/2007WO2007117409A2 Opiopathies
10/18/2007WO2007117401A2 Indoles and benzoimidazoles as modulators of the histamine h4 receptor
10/18/2007WO2007117399A2 Benzoimidazol-2-yl pyrimidines and pyrazines as modulators of the histamine h4 receptor
10/18/2007WO2007117398A2 Non-peptidic molecules for detecting and treating tumors
10/18/2007WO2007117394A2 Compositions and methods related to fructosamine-3-kinase inhibitors
10/18/2007WO2007117289A2 Methods for treating or preventing erectile dysfunction or urinary incontinence
10/18/2007WO2007117286A2 Methods for treating cerebrovascular disease by administering desmethylselegiline
10/18/2007WO2007117272A2 Methods for treatment of hemorrhagic shock and related disorders
10/18/2007WO2007117241A1 Intramuscular antiviral treatments
10/18/2007WO2007117180A1 Azaheterocycles, combinatory library, focused library, pharmaceutical composition and methods for the production thereof
10/18/2007WO2007117175A1 Pharmaceutical composition of enterosorbent and prebiotics, dosage forms, and the method for prevention and treatment of gastrointestinal disorders
10/18/2007WO2007117165A1 New pharmaceutical compounds
10/18/2007WO2007117161A1 Substituted ring fused azines and their use in cancer therapy
10/18/2007WO2007117111A1 A phamaceutical composition for treating allergic diseases
10/18/2007WO2007117102A1 Complex antibiotic composition for bovine mastitis
10/18/2007WO2007117038A1 Prophylactic/therapeutic agent for cancer
10/18/2007WO2007117022A1 Chewing composition comprising coenzyme q10
10/18/2007WO2007116981A1 Fat accumulation inhibitor
10/18/2007WO2007116980A1 Suppressor of increase in blood glucose level
10/18/2007WO2007116960A1 Oxazolidinone derivative having carbocyclic ring
10/18/2007WO2007116916A1 Liquid drug preparation for oral administration
10/18/2007WO2007116901A1 Novel arylamide derivative
10/18/2007WO2007116866A1 Hetero compound
10/18/2007WO2007116731A1 Composition containing reduced coenzyme a
10/18/2007WO2007116579A1 Lypolysis promoter
10/18/2007WO2007116458A1 Therapeutic agent for neurodegenerative disease
10/18/2007WO2007116432A1 Anti-inflammatory agent and cancer-preventive agent comprising canolol or prodrug thereof and pharmaceutical, cosmetic and food comprising the same
10/18/2007WO2007116428A2 Oral pharmaceutical composition containing cystine or cysteine with glutathione against oxidative stress resulting from haemodialysis
10/18/2007WO2007116404A2 Cucurbitacin glucosides and use thereof in treating cancer
10/18/2007WO2007116396A1 Treatment of hematological malignancies with fts and a bcr-abl tyrosine kinase inhibitor
10/18/2007WO2007116375A2 Municipal casting frame and method of manufacturing same
10/18/2007WO2007116374A1 Novel sulfonamide compounds
1 ... 3537 3538 3539 3540 3541 3542 3543 3544 3545 3546 3547 3548 3549 3550 3551 3552 3553 3554 3555 3556 3557 ... 7860